| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HARROW, INC. | CEO of ImprimisRx | Common stock | 300K | $12.4M | $41.37 | Sep 11, 2024 | Direct |
| HARROW, INC. | CEO of ImprimisRx | RSU | 0 | Feb 20, 2024 | Direct | ||
| HARROW, INC. | CEO of ImprimisRx | Stock Option (Right to Buy) | 0 | Sep 11, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HROW | HARROW, INC. | Sep 11, 2024 | 3 | -$1.2M | 4 | Sep 13, 2024 | CEO of ImprimisRx |
| HROW | HARROW, INC. | Mar 1, 2024 | 2 | $43.8K | 4 | Mar 6, 2024 | CEO of ImprimisRx |
| HROW | HARROW, INC. | Feb 20, 2024 | 3 | $185K | 4 | Feb 21, 2024 | CEO of ImprimisRx |
| HROW | HARROW, INC. | Nov 10, 2023 | 3 | -$125K | 4 | Nov 14, 2023 | Chief Commercial Officer |
| HROW | HARROW HEALTH, INC. | Jul 18, 2023 | 3 | -$1.99M | 4 | Jul 20, 2023 | Chief Commercial Officer |
| HROW | HARROW HEALTH, INC. | Apr 3, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Chief Commercial Officer |
| HROW | HARROW HEALTH, INC. | Feb 19, 2022 | 3 | -$204K | 4 | Feb 23, 2022 | President, ImprimisRx |
| HROW | HARROW HEALTH, INC. | Jul 23, 2021 | 1 | $0 | 4 | Jul 23, 2021 | President, ImprimisRx |